ID

16834

Description

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00184613

Lien

https://clinicaltrials.gov/show/NCT00184613

Mots-clés

  1. 09/08/2016 09/08/2016 -
Téléchargé le

9 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT00184613

Eligibility Diabetes NCT00184613

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00184613
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with type 2 diabetes for more than 2 years
Description

Type 2 diabetes

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
subjects currently treated with unchanged insulin glargine dose (10 -100 units) for 2 weeks
Description

insulin glargine

Type de données

boolean

Alias
UMLS CUI [1]
C0907402
subjects currently treated with unchanged dose(s) for at least 1 month on one or two oral anti-diabetic drugs
Description

oral anti-diabetic drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0359086
bmi 25 - 40 kg/m2
Description

BMI

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
hba1c < 9.5 %
Description

HbA1C

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product(s) or related products
Description

allergy to trial product(s) or related products

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0907402
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0123677
previous randomisation in this trial
Description

previous randomisation in this trial

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures (only sterilisation, intra uterine devices and contraceptive pills are considered adequate contraceptive methods)
Description

pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C2081645
UMLS CUI [4]
C0700589
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation.
Description

mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
any other significant illness such as endocrine, cardiac, neurological, malignant or other pancreatic illness judged by investigator
Description

other significant illness

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
participation in other studies within the last three months
Description

participation in other studies

Type de données

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Diabetes NCT00184613

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00184613
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes
Item
subjects with type 2 diabetes for more than 2 years
boolean
C0011860 (UMLS CUI [1])
insulin glargine
Item
subjects currently treated with unchanged insulin glargine dose (10 -100 units) for 2 weeks
boolean
C0907402 (UMLS CUI [1])
oral anti-diabetic drugs
Item
subjects currently treated with unchanged dose(s) for at least 1 month on one or two oral anti-diabetic drugs
boolean
C0359086 (UMLS CUI [1])
BMI
Item
bmi 25 - 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
HbA1C
Item
hba1c < 9.5 %
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
allergy to trial product(s) or related products
Item
known or suspected allergy to trial product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0123677 (UMLS CUI [2,2])
previous randomisation in this trial
Item
previous randomisation in this trial
boolean
C2348568 (UMLS CUI [1])
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures
Item
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures (only sterilisation, intra uterine devices and contraceptive pills are considered adequate contraceptive methods)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C2081645 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation
Item
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
other significant illness
Item
any other significant illness such as endocrine, cardiac, neurological, malignant or other pancreatic illness judged by investigator
boolean
C0009488 (UMLS CUI [1])
participation in other studies
Item
participation in other studies within the last three months
boolean
C2348568 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial